Logo

ELIXIR Becomes Independent Legal Entity

Dec 21, 2013
Premium

The European Bioinformatics Institute said this week that the European Life-science Infrastructure for Biological Information (ELIXIR) project has become an independent legal entity.

The transition occurred after Estonia became the fifth country to ratify the ELIXIR Consortium Agreement. Other signatories include the United Kingdom, Sweden, Switzerland, the Czech Republic, and the European Molecular Biology Laboratory.

According to the EBI, this marks the formal launch of the infrastructure for biological data that will support life science research in Europe, and its translation to medicine, the bio-industries, and society

Filed under

Informatics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.